# FDA recall D-0131-2020

> **Teva Pharmaceuticals USA** · Class III · drug recall initiated 2019-09-06.

## Product

Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ  NDC 52544-692-30

## Reason for recall

GMP Deviation: lot not intended for commercial distribution.

## Distribution

Product was distributed to 42 wholesalers and 11 retailers who may have further distribute the product throughout the United States, including Hawaii and Puerto Rico.

## Key facts

- **Recall number:** D-0131-2020
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-09-06
- **Report date:** 2019-10-16
- **Termination date:** 2020-05-19

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0131-2020

## Citation

> AI Analytics. FDA recall D-0131-2020. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-0131-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*